117
Participants
Start Date
September 1, 2015
Primary Completion Date
May 2, 2017
Study Completion Date
May 2, 2017
PRM-151
PRM 151 10 mg/kg IV infusion over 60 minutes days 1, 3, and 5, then one infusion every 4 weeks
placebo
Placebo IV infusion over 60 minutes on days 1, 3, and 5, then one infusion every 4 weeks
Thomayer Hospital, Prague
Azienda Ospedaliera San Gerardo, Monza
Inova Fairfax Hospital, Falls Church
University of Louisville Hospital, Louisville
University of Wisconsin-Madison, Madison
University of Kansas Medical Center, Kansas City
UT - Southwestern Medical School, Dallas
National Jewish Medical and Research Center, Denver
UCSF Interstitial Lung Disease Program, San Francisco
University of Washington Medical Center, Seattle
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Justus-Liebig University Giessen, Giessen
Thoraxklinik University of Heidelberg, Heidelberg
Az. Ospedaliera Universitaria-Policlinico V. Emanuele di Catania, Catania
Erasmus Medical Center, Rotterdam
Hospital University de Bellvitge, Barcelona
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Hoffmann-La Roche
INDUSTRY